期刊文献+

氨甲环酸对心脏手术后出血量及并发症影响的对照研究 被引量:10

Effects of tranexamic acid on bleeding and complication after cardiac surgery: a control study
下载PDF
导出
摘要 目的:观察氨甲环酸对心脏手术后出血量的影响。方法:根据临床停止使用抑肽酶的时间,将560例行心脏手术患者分为抑肽酶组(n=303)和氨甲环酸组(n=257),对两组术后失血量、二次开胸止血率、输血量、急性肾功能不全及低心排综合征发生率等进行比较。结果:术后24 h出血量氨甲环酸组为(578.5±386.0)ml,抑肽酶组为(629.3±366.7)ml,两组差异无统计学意义(P=0.111)。二次开胸止血率氨甲环酸组为3.9%,抑肽酶组为4.3%,两组差异无统计学意义(P=0.730)。术后红细胞需求量氨甲环酸组为(2.39±6.20)U,抑肽酶组为(2.08±4.92)U;血浆需求量氨甲环酸组为(1.58±4.85)100 ml,抑肽酶组为(1.67±4.88)100 ml;血小板需求量氨甲环酸组为(1.19±5.12)10 U,抑肽酶组为(1.51±5.29)10 U,两组差异均无统计学意义(分别P=0.149、0.355、0.797)。结论:心脏手术中应用氨甲环酸可有效减少术后出血量及血制品需求量,其效果与抑肽酶相似。 Objective: To investigate the influence of using tranexamic acid during cardiac surgery on reduce postoperative bleeding.Methods: A total of 560 cases were involved,of which 303 in aprotinin group and 257 in tranexamic acid group.Postoperative blood loss,rate of reoperation for excessive postoperative bleeding,transfusion requirements,rate of acute renal failure and low cardiac output syndrome were compared between the two groups.Results: There were no significance differences of postoperative blood loss[(578.5±386.0) ml vs(629.3±366.7) ml,P=0.111] and rate of reoperation for excessive postopearative bleeding(3.9% vs 4.3%,P=0.730) between two groupes.The requirements of red blood cell,plasma,platelets were(2.39±3.20) U,(1.58±4.85)100 ml,(1.19±5.12)10 U in tranexamic acid groupe while(2.08±4.92) U,(1.67±4.88)100 ml、(1.51±5.29)10 U in aprotinin groupe,also showing no significance differences(P=0.149,0.355,0.797).Conclusions: Tranexamic acid is as effective as aprotinin to reduce postoperative bleeding,transfusion requirements during cardiac operation.
出处 《东南大学学报(医学版)》 CAS 2012年第1期101-104,共4页 Journal of Southeast University(Medical Science Edition)
关键词 氨甲环酸 抑肽酶 心脏手术 术后出血量 血制品需求量 tranexamic acid aprotinin cardiac operation postoperative bleeding requirements of transfusion
  • 相关文献

参考文献16

  • 1ICKX B E,LINDEN P J,MELOT C,et al.Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation[J].Transfusion,2006,46(4):595-605.
  • 2VAMVAKAS E C.Pneumonia as a complication of blood product transfusion in the critically ill:transfusion-related immunomodulation(TRIM)[J].Crit Care Med,2006,34(5 Suppl):S151-159.
  • 3SCHOUTEN E S,van de POL A C,SCHOUTEN A N,et al.The effect of aprotinin,tranexamic acid,and aminocaproic acid on blood loss and use of blood products in major pediatric surgery:a meta-analysis[J].Pediatr Crit Care Med,2009,10(2):182-190.
  • 4MANGANO D T,TUDOR I C,DIETZEL C,et al.The risk associated with aprotinin in cardiac surgery[J].N Engl J Med,2006,354:353-365.
  • 5MANGANO D T,MIAO Y,VUYLSTEKE A,et al.Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery[J].JAMA,2007,297(5):471-479.
  • 6FERGUSSON D A,HEBERT P C,MAZER C D,et al.A comparison of aprotinin and lysine analogues in high-risk cardiac surgery[J].N Engl J Med,2008,358:2319-2331.
  • 7KUITUNEN A,HIIPPALA S,VAHTERA E,et al.The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery[J].Acta Anaesthesiol Scand,2005,49(9):1272-1279.
  • 8YASIM A,ASIK R,ATAHAN E.Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery[J].Anadolu Kardiyol Derg,2005,5(1):36-40.
  • 9KARKOUTI K,BEATTIE W S,DATTILO K M,et al.A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery[J].Transfusion,2006,46(3):327-338.
  • 10AIT H M,SELKANE C,AMAHZOUNE B,et al.Antifibrinolytic agents and repeat open-heart surgery:a comparison of tranexamic acid and low dose aprotinin[J].Ann Cardiol Angeiol(Paris),2007,56(6):308-312.

二级参考文献8

  • 1陈良万,薛松.体外循环中纤溶系统的改变及止血芳酸对其的影响[J].中华胸心血管外科杂志,1996,12(5):311-312. 被引量:24
  • 2SOSLAU G,HORROW BRODSKY I,et al.Effect of tranexamic acid on platelet ADP during extracorporeal circulation[J].Am J Hematol,1991,38:113-119.
  • 3ALLEN S,KHAN S,TAM S P,et al.Expression of adhesion molecules by lp(a):a potential novel mechanism for its atherogenicity[J].FASEB-J,1998,12:1765-1776.
  • 4HUNFELD A,ETSCHEID M,KONIG H,et al.Detection of a novel plasma serine protease during purification of vitamin K dependent coagulation factors[J].FEBS Lett,1999,456:290-294.
  • 5RAY M J,MARSH N A.Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin[J].Thromb Haemost,1997,78:1021-1026.
  • 6GELB A B,ROTH R I,LEVIN J,et al.Changes in blood coagulation during and following cardiopulmonary bypass:lack of correlation with clinical bleeding[J].Am J Clin Pathol,1996,106:87-99.
  • 7LORENZINI J L,DUTRILLAUX F,MOUSSON C,et al.Extracorporeal circuit heparinization in selective low density lipoprotein apheresis:changes in patient hemostasis and low molecular weight heparin benefit[J].J Clin Apheresis,1993,8:141-146.
  • 8HARKER L,MALPASS T W,BRANSON H E,et al.Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass:Acquired transient dysfunction associated with selective a-granule release[J].Blood,1980,56:824.

共引文献3

同被引文献110

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部